Easterly Investment Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Sell |
13,536
-9,825
| -42% | -$815K | 0.08% | 141 |
|
|
2025
Q1 | $1.89M | Buy |
23,361
+5,300
| +29% | +$430K | 0.16% | 113 |
|
|
2024
Q4 | $1.63M | Hold |
18,061
| – | – | 0.13% | 127 |
|
|
2024
Q3 | $1.78M | Hold |
18,061
| – | – | 0.14% | 126 |
|
|
2024
Q2 | $1.67M | Hold |
18,061
| – | – | 0.15% | 120 |
|
|
2024
Q1 | $1.71M | Sell |
18,061
-5,001
| -22% | -$475K | 0.13% | 133 |
|
|
2023
Q4 | $2.06M | Sell |
23,062
-5,000
| -18% | -$446K | 0.22% | 99 |
|
|
2023
Q3 | $2.05M | Buy |
28,062
+5,000
| +22% | +$365K | 0.23% | 97 |
|
|
2023
Q2 | $1.92M | Buy |
23,062
+1,000
| +5% | +$83.2K | 0.17% | 109 |
|
|
2023
Q1 | $1.68M | Buy |
22,062
+470
| +2% | +$35.8K | 0.15% | 116 |
|
|
2022
Q4 | $1.79M | Buy |
21,592
+3,501
| +19% | +$291K | 0.15% | 116 |
|
|
2022
Q3 | $1.44M | Sell |
18,091
-10,000
| -36% | -$793K | 0.14% | 120 |
|
|
2022
Q2 | $2.09M | Buy |
28,091
+10,000
| +55% | +$743K | 0.19% | 103 |
|
|
2022
Q1 | $1.63M | Buy |
+18,091
| New | +$1.63M | 0.12% | 122 |
|